CUSIP: 33830X104
Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
22,183,174
-
Share change
-
-885,222
-
Total reported value
-
$920,587,408
-
Put/Call ratio
-
766%
-
Price per share
-
$41.50
-
Number of holders
-
128
-
Value change
-
-$5,930,336
-
Number of buys
-
70
-
Number of sells
-
56
Quarterly Holders Quick Answers
What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2016
-
Previous quarter:
Q3 2015
Recent filing periods for CUSIP 33830X104:
Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q4 2015
As of 31 Dec 2015,
FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,183,174 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP LLC, EVENTIDE ASSET MANAGEMENT, LLC, Versant Venture Management, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, EcoR1 Capital, LLC, DEERFIELD MANAGEMENT CO, STATE STREET CORP, and BlackRock Institutional Trust Company, N.A..
This page lists
128
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.